AVROBIO, Inc. (NASDAQ:AVRO) has been assigned a consensus recommendation of “Buy” from the ten ratings firms that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that […]
